LivingPHOENIX Previews POGMENT® Collagen ECM Devices

LivingPHOENIX Regenerative Technology Development (Chengdu) Co., Ltd. presented a global launch preview for its POGMENT® Triple-Helix Biomimetic Collagen-Based Extracellular Matrix medical devices at the 19th EU-China Business Meeting in Chengdu, China.

According to Manilatimes, the meeting was co-hosted by the China Chamber of International Commerce and the European Union Chamber of Commerce in China. Dr. Qin Xingjiong, LivingPHOENIX’s founder, attended with the company’s industrialization team and witnessed the preview ceremony for the company’s core product.

Collagen-based ECM device preview

The POGMENT® platform is described by Manilatimes as a third-generation triple-helix biomimetic collagen-based extracellular matrix medical-device offering. The preview placed the product at an international business event focused on EU-China engagement.

For medical-device sales professionals, the announcement centers on a regenerative medicine materials platform and its public introduction. The company positioned the presentation as a milestone for its industrialization work and international visibility.

Company positioning at the event

Manilatimes reported that LivingPHOENIX is a tenant enterprise of Tianfu International Bio City. The publisher said the company characterized the launch as demonstrating Chinese intelligent manufacturing to the international market.

The report also stated that the company views the product presentation as part of China’s progress in high-end regenerative medicine materials. The announcement did not provide additional details on clinical indications, commercial availability, regulatory status, or product specifications.

What the announcement establishes

• LivingPHOENIX held a global launch preview ceremony for POGMENT® at the 19th EU-China Business Meeting.
• The product is identified as a triple-helix biomimetic collagen-based ECM medical-device platform.
• Dr. Qin Xingjiong and the company’s industrialization team attended the event.
• The event took place in Chengdu, China.

Medical-device commercial teams tracking regenerative materials can note the distinction between the reported preview ceremony and any later product, regulatory, or market-distribution updates.